We are live on ! Find out more
MFIM

Mesirow Financial Investment Management Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+23.22%
3 Year Est. Return
+69.99%
5 Year Est. Return
+94.22%
10 Year Est. Return
AUM
$5.03B
AUM Growth
-$134M
Cap. Flow
-$146M
Cap. Flow %
-2.89%
Top 10 Hldgs %
37.84%
Holding
630
New
37
Increased
289
Reduced
208
Closed
34

Sector Composition

Rank Sector Weight
1 Financials 15.14%
2 Technology 13.38%
3 Industrials 5.56%
4 Communication Services 5.14%
5 Healthcare 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
551
Cummins
CMI
$87.8B
$202K ﹤0.01%
+579
New +$203K
HRL icon
552
Hormel Foods
HRL
$13.4B
$201K ﹤0.01%
+6,405
New +$201K
JEF icon
553
Jefferies Financial Group
JEF
$12.6B
$201K ﹤0.01%
+2,559
New +$184K
PHX
554
DELISTED
PHX Minerals
PHX
$190K ﹤0.01%
47,542
+570
+1% +$2.1K
SD icon
555
SandRidge Energy
SD
$529M
$182K ﹤0.01%
15,574
+178
+1% +$2.06K
NU icon
556
Nu Holdings
NU
$65.5B
$180K ﹤0.01%
17,347
-3,980
-19% -$52.9K
BCAL icon
557
Southern California Bancorp
BCAL
$701M
$176K ﹤0.01%
10,668
VTRS icon
558
Viatris
VTRS
$18.5B
$175K ﹤0.01%
14,097
-19,737
-58% -$243K
STOK icon
559
Stoke Therapeutics
STOK
$2.13B
$174K ﹤0.01%
15,779
+175
+1% +$2.15K
HLX icon
560
Helix Energy Solutions
HLX
$1.49B
$170K ﹤0.01%
18,215
+215
+1% +$2.16K
COGT icon
561
Cogent Biosciences
COGT
$6.76B
$170K ﹤0.01%
21,736
+241
+1% +$2.4K
FOLD
562
DELISTED
Amicus Therapeutics
FOLD
$160K ﹤0.01%
16,936
SILV
563
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$146K ﹤0.01%
16,000
CMBT
564
CMB.TECH NV
CMBT
$4.86B
$140K ﹤0.01%
14,054
+3,043
+28% +$39.4K
RLAY icon
565
Relay Therapeutics
RLAY
$4.4B
$136K ﹤0.01%
32,916
+18,380
+126% +$100K
SNDX icon
566
Syndax Pharmaceuticals
SNDX
$1.77B
$135K ﹤0.01%
10,242
+116
+1% +$1.99K
BHK icon
567
BlackRock Core Bond Trust
BHK
$659M
$132K ﹤0.01%
12,608
+128
+1% +$1.45K
NAC icon
568
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
$126K ﹤0.01%
11,183
+281
+3% +$3.25K
ICCC icon
569
ImmuCell
ICCC
$99.3M
$125K ﹤0.01%
24,356
+12,178
+100% +$48.5K
ICLN icon
570
iShares Global Clean Energy ETF
ICLN
$2.12B
$122K ﹤0.01%
10,686
-15,581
-59% -$197K
POCI icon
571
Precision Optics
POCI
$45.4M
$113K ﹤0.01%
23,364
ADPT icon
572
Adaptive Biotechnologies
ADPT
$4.02B
$112K ﹤0.01%
18,715
DUOT icon
573
Duos Technologies
DUOT
$293M
$112K ﹤0.01%
18,760
OABI icon
574
OmniAb
OABI
$497M
$109K ﹤0.01%
30,764
+366
+1% +$1.45K
CSBR icon
575
Champions Oncology
CSBR
$68.8M
$103K ﹤0.01%
12,000

Similar funds

Mesirow Financial Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Mesirow Financial Investment Management held 630 positions worth $5.03B, down 2.6% from $5.17B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mesirow Financial Investment Management's Q4 2024 filing shows 37 new, 289 increased, 208 reduced and 34 closed positions. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 261,018 shares worth $6.5M. The largest sale was Vanguard High Dividend Yield ETF, an estimated $69.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Mesirow Financial Investment Management's largest Q4 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 261,018 shares worth $6.5M.
  • Mesirow Financial Investment Management added most to VanEck Morningstar Wide Moat ETF in Q4 2024, an estimated $82.7M increase.
  • Mesirow Financial Investment Management's biggest Q4 2024 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $69.8M.
  • Mesirow Financial Investment Management fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $13.7M.
  • Mesirow Financial Investment Management's ten largest holdings make up 38% of its $5.03B portfolio in Q4 2024.
  • Mesirow Financial Investment Management opened 37 new positions and closed 34 in Q4 2024.
  • Mesirow Financial Investment Management's portfolio value fell 2.6% quarter-over-quarter to $5.03B.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.